• Handheld Thermo Scientific Niton XRF analyzers are engineered for portable elemental analysis
  • Proton OnSite - LCMS Gas Generators
  • LeddarTech
Posted in | Materials Testing | Business

Malvern to Develop and Licence Paraytec ActiPix UV Imaging Technology

Published on July 20, 2011 at 8:48 PM

Malvern Instruments Ltd (Malvern, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec's ActiPix technology being added to Malvern's materials characterization portfolio. The agreement will give Malvern exclusive rights to further develop, market and sell ActiPix UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.

Paul Walker, Managing Director of Malvern Instruments, said, "We are delighted to be adding Paraytec's innovative UV area imaging technology to our capability. We see it as complementary to our existing technology portfolio and it offers great potential for further developing and enhancing our product range for particle size and viscosity determination."

Mark Vaux, Paraytec CEO, said, "This is a landmark agreement for our company. To have been selected by Malvern is a huge endorsement of our technology. We look forward to working with the team at Malvern and to seeing Malvern products incorporating our ActiPix technology being launched in due course."

Malvern Instruments is a market leader in measuring performance controlling material properties, including particle size, particle shape, zeta potential, molecular weight, size and conformation, rheological properties and chemical identification. 

Paraytec manufactures and distributes instrumentation for pharmaceutical and biopharmaceutical applications based on its patented ActiPix technology, a 2-dimensional detection platform for UV-Vis absorbance measurement, using capillaries and flow cells in conjunction with sophisticated optics and active pixel area sensors.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit